Alonso, RodrigoPerez de Isla, LeopoldoMuñiz-Grijalvo, OvidioDiaz-Diaz, Jose LuisMata, Pedro2025-01-072025-01-072018https://hdl.handle.net/10668/25880Familial hypercholesterolaemia is the most common monogenic disorder associated with premature coronary artery disease. Mutations are most frequently found in the LDL receptor gene. Clinical criteria can be used to make the diagnosis; however, genetic testing will confirm the disorder and is very useful for cascade screening. Early identification and adequate treatment can improve prognosis, reducing negative clinical cardiovascular outcomes. Patients with familial hypercholesterolaemia are considered at high cardiovascular risk and the treatment target is LDL cholesterolenFamilial hypercholesterolaemiacascade screeninggenetic testingstatinsresearch article30310464open access10.15420/ecr.2018:10:21758-3764PMC6159470https://www.ecrjournal.com/system/files/articles/ECR13-1_14-20.pdfhttps://pmc.ncbi.nlm.nih.gov/articles/PMC6159470/pdf